First Time Loading...

Deciphera Pharmaceuticals Inc
NASDAQ:DCPH

Watchlist Manager
Deciphera Pharmaceuticals Inc Logo
Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Watchlist
Price: 25.38 USD Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

DCPH Price Targets Summary
Deciphera Pharmaceuticals Inc

Wall Street analysts forecast DCPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DCPH is 26.91 USD with a low forecast of 23.23 USD and a high forecast of 31.5 USD.

DCPH Lowest Forecast
Wall Street Target
23.23 USD
8% Downside
DCPH Average Forecast
Wall Street Target
26.91 USD
6% Upside
DCPH Highest Forecast
Wall Street Target
31.5 USD
24% Upside
Lowest
Price Target
23.23 USD
8% Downside
Average
Price Target
26.91 USD
6% Upside
Highest
Price Target
31.5 USD
24% Upside

DCPH Last Price Targets
Deciphera Pharmaceuticals Inc

The latest public price target was made on Apr 30, 2024 by Peter Lawson from Barclays , who expects DCPH stock to rise by 2% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Peter Lawson
Barclays
26 USD
Upside 2%
4 days ago
Apr 30, 2024
Barclays Upgrades Deciphera (DCPH) to Equalweight
StreetInsider
Christopher Raymond
Raymond James
25.6 USD
Upside 1%
5 days ago
Apr 29, 2024
Deciphera downgraded to Neutral from Overweight at Piper Sandler
TheFly
Eun Yang
Jefferies
25.6 USD
Upside 1%
5 days ago
Apr 29, 2024
Jefferies Downgrades Deciphera (DCPH) to Hold
StreetInsider
Unknown Analyst
Leerink Partners
30 USD
Upside 18%
1 year ago
Feb 7, 2023
SVB Leerink Maintains Outperform on Deciphera Pharmaceuticals, Raises Price Target to $30
Benzinga
Peter Lawson
Barclays
Price Target 26 USD
Upside/Downside 2%
View Source
Christopher Raymond
Raymond James
Price Target 25.6 USD
Upside/Downside 1%
View Source
Eun Yang
Jefferies
Price Target 25.6 USD
Upside/Downside 1%
View Source
Unknown Analyst
Leerink Partners
Price Target 30 USD
Upside/Downside 18%
View Source
Deciphera Pharmaceuticals Inc Competitors:
Price Targets
VITR
Vitrolife AB
33% Upside
A
AELIS
Aelis Farma SA
62% Upside
MYGN
Myriad Genetics Inc
25% Upside
IOVA
Iovance Biotherapeutics Inc
95% Upside
VITR
Vitrolife AB
33% Upside
A
AELIS
Aelis Farma SA
62% Upside
MYGN
Myriad Genetics Inc
25% Upside
IOVA
Iovance Biotherapeutics Inc
95% Upside
1672
Ascletis Pharma Inc
114% Upside
688319
Chengdu Olymvax Biopharmaceuticals Inc
169% Upside
P
000403
Pacific Shuanglin Bio pharmacy Co Ltd
10% Downside
AMRN
Amarin Corporation PLC
21% Upside

Revenue
Forecast

Revenue Estimate
Deciphera Pharmaceuticals Inc

The compound annual growth rate of Deciphera Pharmaceuticals Inc's revenue for the next 3 years is 32%.

N/A
Past Growth
32%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Deciphera Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Deciphera Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss
What are analyst estimates?

See Also

Summary
DCPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
DCPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DCPH stock valuation using valuation multiples.
Wall Street Estimates
DCPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DCPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DCPH's stock price target?
Price Target
26.91 USD

According to Wall Street analysts, the average 1-year price target for DCPH is 26.91 USD with a low forecast of 23.23 USD and a high forecast of 31.5 USD.

What is Deciphera Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
32%

The compound annual growth rate of Deciphera Pharmaceuticals Inc's revenue for the next 3 years is 32%.

ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.